HYDERABAD: The Environment Protection and Training Research Institute (EPTRI) took on the CSIR Scientists Service Forum accusing it of being `antidevelopment' in its stance on the Hyderabad Pharma

The United States is pressing India not to extend price caps on medical devices and wants New Delhi to allow firms to withdraw products from the market if they do not wish to sell at government det

This massive industrial park is expected to create jobs for 1.5 million people once fully developed

CHENNAI: Pharmaceutical major Strides Shasun, which has secured the US Food and Drug Administration’s approval for its three plants in Puducherry and Cuddalore, is facing trouble.

Price control of Oral Rehydration Salt (ORS), a life-saving intervention for diarrhoea, is mired in controversy as the company with the largest share in the ORS market has challenged the ceiling pr

CHENNAI: A shortage of drugs has affected the state since July 1 when the Goods and Services Tax (GST) kicked in, with dealers and distributors uncertain over the taxation structure and facing soft

National Institute of Virology to receive Sun Pharma's drug molecules for testing against 3 diseases